Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...

The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that ...

Medicare will soon start paying lower prices for Novo Nordisk’s weight- loss drug Wegovy and its Type 2 diabetes treatment ...

The Centers for Medicare & Medicaid Services says the 15 drugs are Ozempic, Rybelsus and Wegovy; Trelegy Ellipta; Xtandi; ...

The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027 ...

HHS adds 15 drugs to Medicare Part D price negotiations, targeting cost reductions under the Inflation Reduction Act. New ...

Weight loss drugs like Ozempic and Wegovy ... or 4), your portion of costs will be higher. For example, you could pay about 25% to 50% of the drug's full price. Wegovy could be covered by some ...

If your plan covers this drug, your cost will depend on how it’s classified under your plan. However, how much you might pay out of pocket under Medicare ... Media does not transact the business ...

Prosthetic devices are covered under Medicare Part B as durable medical equipment (DME). In many cases, the cost is almost entirely ... Healthline Media does not transact the business of insurance ...

The policy would likely be politically popular but could cost the programs tens of billions of dollars. There’s bipartisan interest in Congress in letting Medicare cover anti-obesity medications ...

Ozempic and Wegovy are among the 15 drugs added to Medicare's list of medications that will be negotiated for lower prices. This is part of an effort to lower prescription drug prices for Medicare ...